Zhen-Yu He Selected Research

Progesterone Receptors (Progesterone Receptor)

10/2023	Nomogram Update to Predict the High Genomic Risk Breast Cancer by Different Races.
1/2023	Impact of the 21-gene expression assay on treatment decisions and clinical outcomes in breast cancer with one to three positive lymph nodes.
1/2020	Incorporation of biologic factors for the staging of de novo stage IV breast cancer.
1/2019	Prognostic impact of the pretreatment albumin to alkaline phosphatase ratio for nonmetastatic breast cancer patients.
1/2019	Progesterone receptor status and tumor grade predict the 21-gene recurrence score of invasive lobular breast cancer.
11/2018	The effects of postoperative radiotherapy on survival outcomes in patients under 65 with estrogen receptor positive tubular breast carcinoma.
8/2017	Men and women show similar survival outcome in stage IV breast cancer.
1/2016	Progesterone receptor loss identifies hormone receptor-positive and HER2-negative breast cancer subgroups at higher risk of relapse: a retrospective cohort study.
1/2016	Patterns of distant metastasis in Chinese women according to breast cancer subtypes.
12/2015	Breast Cancer Subtype is Associated With Axillary Lymph Node Metastasis: A Retrospective Cohort Study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhen-Yu He Research Topics

Disease

69	Breast Neoplasms (Breast Cancer) 10/2023 - 01/2010
46	Neoplasms (Cancer) 10/2023 - 11/2008
15	Neoplasm Metastasis (Metastasis) 01/2022 - 10/2010
7	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2017 - 01/2015
6	Lymphatic Metastasis 12/2019 - 10/2010
5	Triple Negative Breast Neoplasms 01/2024 - 11/2020
5	Nasopharyngeal Carcinoma 10/2019 - 11/2008
5	Adenocarcinoma 01/2019 - 01/2017
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2018 - 01/2017
4	Brain Neoplasms (Brain Tumor) 10/2017 - 01/2016
4	Colorectal Neoplasms (Colorectal Cancer) 01/2017 - 10/2010
3	Carcinoma (Carcinomatosis) 01/2020 - 01/2017
3	Inflammation (Inflammations) 01/2020 - 01/2020
3	Pain (Aches) 10/2019 - 01/2014
3	Ovarian Neoplasms (Ovarian Cancer) 04/2018 - 01/2015
3	Esophageal Neoplasms (Esophageal Cancer) 11/2016 - 01/2016
3	Esophageal Squamous Cell Carcinoma 11/2015 - 01/2015
2	Neoplasm Micrometastasis 10/2019 - 10/2010
2	Ductal Carcinoma 10/2019 - 01/2019
2	Stomatitis 10/2019 - 01/2014
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2017 - 02/2017
2	Type 2 Diabetes Mellitus (MODY) 01/2016 - 01/2016
2	Body Weight (Weight, Body) 01/2013 - 03/2011
1	COVID-19 10/2021
1	Hand-Foot Syndrome 01/2021
1	Stomach Neoplasms (Stomach Cancer) 01/2020
1	Sarcopenia 01/2020
1	Rupture 03/2019
1	Pathologic Processes 01/2019
1	Lobular Carcinoma 01/2019
1	Residual Neoplasm 04/2018
1	Ovarian Epithelial Carcinoma 04/2018
1	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2018
1	Signet Ring Cell Carcinoma 08/2017
1	Adenoid Cystic Carcinoma (Cylindroma) 02/2017
1	Adenosquamous Carcinoma 01/2017
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 03/2016
1	Diabetes Mellitus 01/2016
1	Small Cell Carcinoma 01/2016
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2016
1	Colonic Neoplasms (Colon Cancer) 01/2016
1	Bacillary Dysentery (Shigellosis) 01/2016
1	Amenorrhea 01/2015

Drug/Important Bio-Agent (IBA)

18	Estrogen ReceptorsIBA 01/2023 - 10/2012
12	Progesterone Receptors (Progesterone Receptor)IBA 10/2023 - 10/2012
9	Hormones (Hormone)IBA 10/2023 - 01/2015
7	Indicators and Reagents (Reagents)IBA 10/2020 - 01/2015
6	human ERBB2 proteinIBA 09/2017 - 10/2012
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2010
4	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2017
3	Long Noncoding RNAIBA 01/2017 - 01/2016
2	Capecitabine (Xeloda)FDA Link 01/2024 - 01/2021
2	Epidermal Growth Factor (EGF)IBA 10/2023 - 01/2020
2	Circular RNAIBA 01/2023 - 01/2018
2	RNA (Ribonucleic Acid)IBA 01/2023 - 10/2021
2	Biological FactorsIBA 06/2020 - 01/2020
2	AntigensIBA 01/2019 - 01/2016
2	ChemokinesIBA 01/2019 - 01/2016
2	Messenger RNA (mRNA)IBA 01/2019 - 01/2016
2	ErbB Receptors (EGF Receptor)IBA 01/2018 - 06/2017
2	CurcuminIBA 01/2017 - 03/2011
2	Insulin (Novolin)FDA Link 01/2016 - 01/2016
2	ABO Blood-Group SystemIBA 01/2015 - 01/2015
1	human MIRN638 microRNAIBA 01/2023
1	WastewaterIBA 10/2021
1	Notch1 ReceptorIBA 01/2020
1	ginsenoside Rg5IBA 01/2020
1	Oxycodone (Oxycontin)FDA LinkGeneric 10/2019
1	Cadherins (E-Cadherin)IBA 07/2019
1	VimentinIBA 07/2019
1	IonsIBA 03/2019
1	AlbuminsIBA 01/2019
1	Alkaline PhosphataseIBA 01/2019
1	Replication Protein C (Replication Factor C)IBA 02/2017
1	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 01/2016
1	Carcinoembryonic AntigenIBA 01/2016
1	MicroRNAs (MicroRNA)IBA 01/2016
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2016
1	Amino Acids FDA Link 01/2016
1	CalciumIBA 01/2016
1	CarbohydratesIBA 01/2016
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2016
1	Goserelin (Zoladex)FDA Link 01/2015

Therapy/Procedure

53	Radiotherapy 01/2023 - 01/2010
33	Mastectomy (Mammectomy) 03/2022 - 07/2010
16	Drug Therapy (Chemotherapy) 01/2022 - 01/2015
15	Segmental Mastectomy (Lumpectomy) 01/2022 - 01/2015
12	Lymph Node Excision (Lymph Node Dissection) 01/2019 - 01/2015
9	Therapeutics 01/2024 - 11/2008
8	Adjuvant Radiotherapy 01/2022 - 07/2010
7	Hysterectomy 09/2018 - 01/2015
5	Adjuvant Chemotherapy 01/2024 - 01/2018
5	Chemoradiotherapy 10/2019 - 11/2008
3	Esophagectomy 11/2015 - 01/2015
1	Radical Mastectomy 03/2022
1	Mammaplasty (Breast Reconstruction) 01/2018
1	Combined Modality Therapy 12/2017
1	Operative Surgical Procedures 02/2017
1	Neoadjuvant Therapy 10/2015
1	Cytoreduction Surgical Procedures 01/2015